Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why ISIS Pharmaceuticals, Inc. Climbed This Morning

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.

What: Shares of ISIS Pharmaceuticals, (NASDAQ: ISIS  ) popped 6% today after Deutsche Bank initiated coverage on the biotechnology company with a buy rating.

So what: Along with the call, analyst Alethia Young planted a price target of $60 on the stock, representing 25% worth of upside to yesterday's close. While contrarians might be turned off by ISIS' massive run-up over the past year, Young's sum-of-the-parts valuation analysis suggests that there's plenty of room for the shares to run.

Now what: According to Deutsche, ISIS' risk/reward trade-off remains particularly attractive. "ISIS is a leading platform biotech company with a technology that can silence genes called antisense. We think the platform has significantly evolved and is validated," noted Young. "We see competitive risks on APOC-3 franchise in '14 but think the downside is manageable ($7-10/sh)." So while ISIS' red-hot and volatile shares might not be suited for conservative investors, less risk-averse Fools might want to look into Deutsche's bull call. 

More compelling ways to grow
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2804529, ~/Articles/ArticleHandler.aspx, 9/1/2015 10:31:54 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Brian Pacampara

I take a look at big 10% moves, as well as stock-shaking analyst calls, on a daily basis for The Fool. While I don't believe in active trading, closely monitoring Mr. Market's mood swings can help identify long-term opportunities.

Today's Market

updated Moments ago Sponsored by:
DOW 16,169.42 -358.61 -2.17%
S&P 500 1,930.76 -41.42 -2.10%
NASD 4,689.05 -87.46 -1.83%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 10:15 AM
ISIS $48.49 Down -1.69 -3.37%
Isis Pharmaceutica… CAPS Rating: *****